{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "376970da",
   "metadata": {},
   "outputs": [],
   "source": [
    "from trial_analysis_helper import *\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "18cf216f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded 184 clinical trials from intern_exercise.csv\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>title</th>\n",
       "      <th>objective</th>\n",
       "      <th>outcome_details</th>\n",
       "      <th>phase</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>primary_endpoints_reported_date</th>\n",
       "      <th>prior_concurrent_therapy</th>\n",
       "      <th>start_date</th>\n",
       "      <th>study_design</th>\n",
       "      <th>treatment_plan</th>\n",
       "      <th>...</th>\n",
       "      <th>results_json</th>\n",
       "      <th>study_keywords_json</th>\n",
       "      <th>tags_json</th>\n",
       "      <th>primary_drugs_tested_json</th>\n",
       "      <th>other_drugs_tested_json</th>\n",
       "      <th>therapeutic_areas_json</th>\n",
       "      <th>bmt_other_drugs_tested_json</th>\n",
       "      <th>bmt_primary_drugs_tested_json</th>\n",
       "      <th>ct_gov_listed_locations_json</th>\n",
       "      <th>ct_gov_mesh_terms_json</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>A Phase 1 Randomized, Double Blinded, Placebo-...</td>\n",
       "      <td>To evaluate anti-IL-4 alpha monoclonal antibod...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>I</td>\n",
       "      <td>2021-08-13</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020-09-09</td>\n",
       "      <td>Study Type  :\\tInterventional  (Clinical Trial...</td>\n",
       "      <td>Subjects will receive anti-IL-4 alpha monoclon...</td>\n",
       "      <td>...</td>\n",
       "      <td>[{\"date\": \"2023-03-22T00:00:00Z\", \"details\": \"...</td>\n",
       "      <td>[\"double blind/blinded\", \"immunogenicity\", \"mu...</td>\n",
       "      <td>[]</td>\n",
       "      <td>[{\"drugApprovalStatus\": \"Unapproved\", \"drugId\"...</td>\n",
       "      <td>[]</td>\n",
       "      <td>[{\"id\": 9, \"name\": \"Autoimmune/Inflammation\", ...</td>\n",
       "      <td>[]</td>\n",
       "      <td>[{\"bmtBrandName\": \"611\", \"bmtDrugId\": 42756, \"...</td>\n",
       "      <td>[{\"country\": \"United States\", \"sitesCount\": 1}]</td>\n",
       "      <td>[{\"meshTerm\": \"Dermatitis, Atopic\"}, {\"meshTer...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>A Prospective, Randomized, Double Blind, Paral...</td>\n",
       "      <td>To study the biosimilarity/bioquivalence in EP...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IV</td>\n",
       "      <td>2019-06-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-08-01</td>\n",
       "      <td>Study Type: Interventional (Clinical Trial)\\nS...</td>\n",
       "      <td>Active Comparator: Reference group\\nDrug: EPRE...</td>\n",
       "      <td>...</td>\n",
       "      <td>[]</td>\n",
       "      <td>[\"bioequivalence\", \"double blind/blinded\", \"ef...</td>\n",
       "      <td>[]</td>\n",
       "      <td>[{\"drugApprovalStatus\": \"Approved\", \"drugId\": ...</td>\n",
       "      <td>[{\"drugApprovalStatus\": \"Approved\", \"drugId\": ...</td>\n",
       "      <td>[{\"id\": 2, \"name\": \"Metabolic/Endocrinology\", ...</td>\n",
       "      <td>[{\"bmtBrandName\": \"epogen\", \"bmtDrugId\": 25, \"...</td>\n",
       "      <td>[{\"bmtBrandName\": \"epiao\", \"bmtDrugId\": 18545,...</td>\n",
       "      <td>[{\"country\": \"Thailand\", \"sitesCount\": 8}]</td>\n",
       "      <td>[{\"meshTerm\": \"Anemia\"}]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>A Prospective, Randomized, Double Blind, Paral...</td>\n",
       "      <td>To establish the bio-similarity/bioequivalence...</td>\n",
       "      <td>EPIAO® demonstrated promising effectiveness an...</td>\n",
       "      <td>III</td>\n",
       "      <td>2021-10-09</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-12-01</td>\n",
       "      <td>Study Type: Interventional\\nStudy Design: Allo...</td>\n",
       "      <td>Subjects will receive Eprex to EPIAO with a 1:...</td>\n",
       "      <td>...</td>\n",
       "      <td>[{\"date\": \"2022-11-24T00:00:00Z\", \"details\": \"...</td>\n",
       "      <td>[\"bioequivalence\", \"double blind/blinded\", \"ef...</td>\n",
       "      <td>[]</td>\n",
       "      <td>[{\"drugApprovalStatus\": \"Approved\", \"drugId\": ...</td>\n",
       "      <td>[{\"drugApprovalStatus\": \"Approved\", \"drugId\": ...</td>\n",
       "      <td>[{\"id\": 2, \"name\": \"Metabolic/Endocrinology\", ...</td>\n",
       "      <td>[{\"bmtBrandName\": \"epogen\", \"bmtDrugId\": 25, \"...</td>\n",
       "      <td>[{\"bmtBrandName\": \"epiao\", \"bmtDrugId\": 18545,...</td>\n",
       "      <td>[{\"country\": \"Russian Federation\", \"sitesCount...</td>\n",
       "      <td>[{\"meshTerm\": \"Anemia\"}]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows × 28 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                               title  \\\n",
       "0  A Phase 1 Randomized, Double Blinded, Placebo-...   \n",
       "1  A Prospective, Randomized, Double Blind, Paral...   \n",
       "2  A Prospective, Randomized, Double Blind, Paral...   \n",
       "\n",
       "                                           objective  \\\n",
       "0  To evaluate anti-IL-4 alpha monoclonal antibod...   \n",
       "1  To study the biosimilarity/bioquivalence in EP...   \n",
       "2  To establish the bio-similarity/bioequivalence...   \n",
       "\n",
       "                                     outcome_details phase  \\\n",
       "0                                                NaN     I   \n",
       "1                                                NaN    IV   \n",
       "2  EPIAO® demonstrated promising effectiveness an...   III   \n",
       "\n",
       "  primary_completion_date primary_endpoints_reported_date  \\\n",
       "0              2021-08-13                             NaN   \n",
       "1              2019-06-01                             NaN   \n",
       "2              2021-10-09                             NaN   \n",
       "\n",
       "   prior_concurrent_therapy  start_date  \\\n",
       "0                       NaN  2020-09-09   \n",
       "1                       NaN  2015-08-01   \n",
       "2                       NaN  2015-12-01   \n",
       "\n",
       "                                        study_design  \\\n",
       "0  Study Type  :\\tInterventional  (Clinical Trial...   \n",
       "1  Study Type: Interventional (Clinical Trial)\\nS...   \n",
       "2  Study Type: Interventional\\nStudy Design: Allo...   \n",
       "\n",
       "                                      treatment_plan  ...  \\\n",
       "0  Subjects will receive anti-IL-4 alpha monoclon...  ...   \n",
       "1  Active Comparator: Reference group\\nDrug: EPRE...  ...   \n",
       "2  Subjects will receive Eprex to EPIAO with a 1:...  ...   \n",
       "\n",
       "                                        results_json  \\\n",
       "0  [{\"date\": \"2023-03-22T00:00:00Z\", \"details\": \"...   \n",
       "1                                                 []   \n",
       "2  [{\"date\": \"2022-11-24T00:00:00Z\", \"details\": \"...   \n",
       "\n",
       "                                 study_keywords_json tags_json  \\\n",
       "0  [\"double blind/blinded\", \"immunogenicity\", \"mu...        []   \n",
       "1  [\"bioequivalence\", \"double blind/blinded\", \"ef...        []   \n",
       "2  [\"bioequivalence\", \"double blind/blinded\", \"ef...        []   \n",
       "\n",
       "                           primary_drugs_tested_json  \\\n",
       "0  [{\"drugApprovalStatus\": \"Unapproved\", \"drugId\"...   \n",
       "1  [{\"drugApprovalStatus\": \"Approved\", \"drugId\": ...   \n",
       "2  [{\"drugApprovalStatus\": \"Approved\", \"drugId\": ...   \n",
       "\n",
       "                             other_drugs_tested_json  \\\n",
       "0                                                 []   \n",
       "1  [{\"drugApprovalStatus\": \"Approved\", \"drugId\": ...   \n",
       "2  [{\"drugApprovalStatus\": \"Approved\", \"drugId\": ...   \n",
       "\n",
       "                              therapeutic_areas_json  \\\n",
       "0  [{\"id\": 9, \"name\": \"Autoimmune/Inflammation\", ...   \n",
       "1  [{\"id\": 2, \"name\": \"Metabolic/Endocrinology\", ...   \n",
       "2  [{\"id\": 2, \"name\": \"Metabolic/Endocrinology\", ...   \n",
       "\n",
       "                         bmt_other_drugs_tested_json  \\\n",
       "0                                                 []   \n",
       "1  [{\"bmtBrandName\": \"epogen\", \"bmtDrugId\": 25, \"...   \n",
       "2  [{\"bmtBrandName\": \"epogen\", \"bmtDrugId\": 25, \"...   \n",
       "\n",
       "                       bmt_primary_drugs_tested_json  \\\n",
       "0  [{\"bmtBrandName\": \"611\", \"bmtDrugId\": 42756, \"...   \n",
       "1  [{\"bmtBrandName\": \"epiao\", \"bmtDrugId\": 18545,...   \n",
       "2  [{\"bmtBrandName\": \"epiao\", \"bmtDrugId\": 18545,...   \n",
       "\n",
       "                        ct_gov_listed_locations_json  \\\n",
       "0    [{\"country\": \"United States\", \"sitesCount\": 1}]   \n",
       "1         [{\"country\": \"Thailand\", \"sitesCount\": 8}]   \n",
       "2  [{\"country\": \"Russian Federation\", \"sitesCount...   \n",
       "\n",
       "                              ct_gov_mesh_terms_json  \n",
       "0  [{\"meshTerm\": \"Dermatitis, Atopic\"}, {\"meshTer...  \n",
       "1                           [{\"meshTerm\": \"Anemia\"}]  \n",
       "2                           [{\"meshTerm\": \"Anemia\"}]  \n",
       "\n",
       "[3 rows x 28 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "input_path = r'intern_exercise.csv'\n",
    "output_path = r'clinical_trial_results.xlsx'\n",
    "df = load_trial_data(input_path)\n",
    "df.head(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "95cbceaa",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Discovered 29 unique candidates\n",
      "Filtering for frequency >= 2...\n",
      "\n",
      "--------------------------------------------------------------------------------\n",
      "  PD-1                           mentioned  59 times\n",
      "  HER2                           mentioned  49 times\n",
      "  VEGF                           mentioned  45 times\n",
      "  IL-5                           mentioned  42 times\n",
      "  IL-17A                         mentioned  40 times\n",
      "  ERYTHROPOIETIN                 mentioned  21 times\n",
      "  IL-1                           mentioned  17 times\n",
      "  IL-4R                          mentioned  10 times\n",
      "  IL-1BETA                       mentioned  10 times\n",
      "  PD-L1                          mentioned   9 times\n",
      "  CD20                           mentioned   7 times\n",
      "  TUMOR NECROSIS FACTOR          mentioned   7 times\n",
      "  INTERLEUKIN-4 RECEPTOR         mentioned   6 times\n",
      "  INTERLEUKIN-4                  mentioned   6 times\n",
      "  BDCA2                          mentioned   4 times\n",
      "  TNF ALPHA                      mentioned   4 times\n",
      "  IL-4 ALPHA                     mentioned   2 times\n",
      "  IL-4                           mentioned   2 times\n",
      "  INTERLEUKIN-1                  mentioned   2 times\n",
      "  IL1                            mentioned   2 times\n",
      "  TUMOR NECROSIS FACTOR-Α        mentioned   2 times\n",
      "  TNF A                          mentioned   2 times\n",
      "  TNF                            mentioned   2 times\n",
      "  IL-4R ALPHA                    mentioned   2 times\n",
      "\n",
      "Total targets discovered: 24\n"
     ]
    }
   ],
   "source": [
    "# Discover molecular targets\n",
    "min_target_frequency = 2 # Minimum number of mentions to consider molecular target valid\n",
    "targets = discover_molecular_targets(df, min_target_frequency, verbose=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "b5373639",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processed 50/184 trials...\n",
      "Processed 100/184 trials...\n",
      "Processed 150/184 trials...\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<Axes: xlabel='Innovation'>"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "results = analyze_all_trials(df, targets)\n",
    "results['Innovation'].value_counts().plot(kind='bar')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "d3aa3336",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✓ Results saved to: clinical_trial_results.xlsx\n"
     ]
    }
   ],
   "source": [
    "# save results\n",
    "save_results(results, targets, output_path)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
